Health & Personal Care
HIGH
FDA DRUG
Glenmark Pharmaceuticals Recalls Nebivolol Tablets Over Contamination
Glenmark Pharmaceuticals recalled 672 bottles of Nebivolol Tablets on November 18, 2025, due to cross-contamination. The 20 mg tablets, prescribed for hypertension, may pose health risks. Consumers should stop using the product and seek guidance from healthcare providers.
NEBIVOLOL
Cross Contamination